T1	AdverseReaction 130 154	Cardiovascular Disorders
T2	AdverseReaction 201 220	Malignant Neoplasms
T3	AdverseReaction 267 286	Gallbladder Disease
T4	AdverseReaction 333 353	Hypertriglyceridemia
T5	AdverseReaction 524 537	muscle spasms
T6	AdverseReaction 539 545	nausea
T7	AdverseReaction 547 555	diarrhea
T8	AdverseReaction 557 566	dyspepsia
T9	AdverseReaction 568 588	abdominal pain upper
T10	AdverseReaction 590 608	oropharyngeal pain
T11	AdverseReaction 610 619	dizziness
T12	AdverseReaction 625 634	neck pain
T13	AdverseReaction 1645 1654	mortality
T14	Negation 1659 1663	0.0%
T15	AdverseReaction 2025 2034	hot flush
T16	AdverseReaction 2036 2056	abdominal pain upper
T17	AdverseReaction 2062 2068	nausea
T18	AdverseReaction 2502 2508	Nausea
T19	AdverseReaction 2611 2619	Diarrhea
T20	AdverseReaction 2720 2729	Dyspepsia
T21	AdverseReaction 2829 2849	Abdominal pain upper
T22	AdverseReaction 2994 3007	Muscle spasms
T23	AdverseReaction 3103 3112	Neck pain
T24	AdverseReaction 3250 3259	Dizziness
T25	AdverseReaction 3416 3434	Oropharyngeal pain
T26	AdverseReaction 3624 3646	venous thromboembolism
T27	AdverseReaction 3648 3670	deep venous thrombosis
T28	AdverseReaction 3672 3690	pulmonary embolism
T29	AdverseReaction 3696 3719	retinal vein thrombosis
T30	AdverseReaction 3776 3798	venous thromboembolism
T31	Negation 3816 3820	0.0%
T32	Factor 3982 3986	risk
T33	AdverseReaction 3990 4012	venous thromboembolism
T34	AdverseReaction 4157 4175	ENDOMETRIAL CANCER
T35	AdverseReaction 4177 4201	CARDIOVASCULAR DISORDERS
T36	Factor 4207 4215	PROBABLE
T37	AdverseReaction 4216 4224	DEMENTIA
T38	AdverseReaction 4240 4258	ENDOMETRIAL CANCER
T39	AdverseReaction 4260 4284	CARDIOVASCULAR DISORDERS
T40	Factor 4290 4298	PROBABLE
T41	AdverseReaction 4299 4307	DEMENTIA
T42	AdverseReaction 4448 4466	endometrial cancer
T43	DrugClass 4511 4520	estrogens
T44	Factor 4547 4562	reduce the risk
T45	AdverseReaction 4566 4589	endometrial hyperplasia
T46	AdverseReaction 5140 5146	stroke
T47	AdverseReaction 5151 5171	deep vein thrombosis
T48	AdverseReaction 5173 5176	DVT
T49	DrugClass 5267 5292	oral conjugated estrogens
T50	AdverseReaction 5479 5487	dementia
T51	DrugClass 5579 5599	conjugated estrogens
T52	AdverseReaction 6111 6129	ENDOMETRIAL CANCER
T53	AdverseReaction 6131 6155	CARDIOVASCULAR DISORDERS
T54	Factor 6161 6169	PROBABLE
T55	AdverseReaction 6170 6178	DEMENTIA
T56	AdverseReaction 6355 6373	endometrial cancer
T57	DrugClass 6418 6427	estrogens
T58	DrugClass 6589 6597	estrogen
T59	AdverseReaction 6641 6647	stroke
T60	AdverseReaction 6652 6672	deep vein thrombosis
T61	AdverseReaction 6674 6677	DVT
T62	DrugClass 6719 6727	estrogen
T63	AdverseReaction 6796 6804	dementia
T64	AdverseReaction 18429 18453	Cardiovascular disorders
T65	AdverseReaction 18465 18487	venous thromboembolism
T66	AdverseReaction 18489 18507	pulmonary embolism
T67	AdverseReaction 18509 18515	stroke
T68	AdverseReaction 18521 18548	retinal vascular thrombosis
T69	AdverseReaction 18572 18591	Malignant neoplasms
T70	AdverseReaction 18603 18621	endometrial cancer
T71	AdverseReaction 18623 18636	breast cancer
T72	AdverseReaction 18642 18656	ovarian cancer
T73	Factor 18695 18699	risk
T74	AdverseReaction 18703 18722	gallbladder disease
T75	Factor 19416 19420	risk
T76	AdverseReaction 19424 19427	VTE
T77	AdverseReaction 19454 19460	stroke
T78	AdverseReaction 19465 19468	DVT
T79	DrugClass 19492 19500	estrogen
T80	AdverseReaction 19990 19996	stroke
T81	DrugClass 20057 20077	conjugated estrogens
T82	Negation 20356 20358	no
T83	AdverseReaction 20377 20383	stroke
T84	DrugClass 20410 20430	conjugated estrogens
T85	AdverseReaction 20730 20752	coronary heart disease
T86	AdverseReaction 20754 20757	CHD
T87	Severity 20778 20786	nonfatal
T88	AdverseReaction 20787 20808	myocardial infarction
T89	AdverseReaction 20810 20838	silent myocardial infarction
T90	AdverseReaction 20843 20852	CHD death
T91	DrugClass 20886 20894	estrogen
T92	Negation 21050 21059	reduction
T93	AdverseReaction 21063 21066	CHD
T94	AdverseReaction 21293 21296	VTE
T95	AdverseReaction 21298 21301	DVT
T96	AdverseReaction 21306 21324	pulmonary embolism
T97	AdverseReaction 21326 21328	PE
T98	DrugClass 21371 21391	conjugated estrogens
T99	AdverseReaction 21504 21507	DVT
T100	AdverseReaction 21596 21599	VTE
T101	Factor 21600 21604	risk
T102	AdverseReaction 22397 22415	endometrial cancer
T103	DrugClass 22460 22468	estrogen
T104	AdverseReaction 22514 22532	endometrial cancer
T105	DrugClass 22554 22562	estrogen
T106	DrugClass 23966 23985	conjugated estrogen
T107	AdverseReaction 24048 24070	invasive breast cancer
T108	DrugClass 24623 24631	estrogen
T109	AdverseReaction 24728 24742	ovarian cancer
T110	DrugClass 25240 25248	estrogen
T111	AdverseReaction 25324 25332	dementia
T112	AdverseReaction 25364 25372	dementia
T113	DrugClass 25377 25379	CE
T114	AdverseReaction 25468 25476	dementia
T115	DrugClass 25481 25483	CE
T116	Factor 25694 25698	risk
T117	AdverseReaction 25702 25721	gallbladder disease
T118	AdverseReaction 25840 25867	Retinal vascular thrombosis
T119	Severity 26283 26294	substantial
T120	AdverseReaction 26295 26322	increases in blood pressure
T121	AdverseReaction 26458 26464;26478 26495	effect of estrogens on blood pressure
T122	Negation 26500 26503	not
T123	Factor 26621 26624	may
T124	AdverseReaction 26644 26678	elevations of plasma triglycerides
T125	AdverseReaction 26690 26702	pancreatitis
T126	AdverseReaction 27620 27654;27661 27667	increased thyroid-binding globulin (TBG) levels
T127	AdverseReaction 27620 27629;27656 27659;27661 27667	increased thyroid-binding globulin (TBG) levels
T128	AdverseReaction 27727 27740	increased TBG
T129	Factor 28180 28183	may
T130	AdverseReaction 28205 28220	fluid retention
T131	Factor 28741 28744	may
T132	AdverseReaction 28745 28755;28768 28778	exacerbate symptoms of angioedema
T133	AdverseReaction 29532 29560	Accelerated prothrombin time
T134	AdverseReaction 29532 29543;29562 29589	Accelerated prothrombin time, partial thromboplastin time
T135	AdverseReaction 29532 29543;29595 29620	Accelerated prothrombin time, partial thromboplastin time, and platelet aggregation time
T136	AdverseReaction 29622 29646	increased platelet count
T137	AdverseReaction 29648 29668	increased factors II
T138	AdverseReaction 29648 29665;29670 29681	increased factors II, VII antigen
T139	AdverseReaction 29648 29665;29683 29695	increased factors II, VII antigen, VIII antigen
T140	AdverseReaction 29648 29665;29697 29720	increased factors II, VII antigen, VIII antigen, VIII coagulant activity
T141	AdverseReaction 29648 29665;29722 29724	increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX
T142	AdverseReaction 29648 29665;29726 29727	increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X
T143	AdverseReaction 29648 29665;29729 29732	increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII
T144	AdverseReaction 29648 29665;29734 29747	increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex
T145	AdverseReaction 29648 29665;29749 29765	increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex, II-VII-X complex
T146	AdverseReaction 29648 29657;29771 29791	increased factors II, VII antigen, VIII antigen, VIII coagulant activity, IX, X, XII, VII-X complex, II-VII-X complex, and beta-thromboglobulin
T147	AdverseReaction 29793 29826	decreased levels of antifactor Xa
T148	AdverseReaction 29793 29812;29831 29847	decreased levels of antifactor Xa and antithrombin III
T149	AdverseReaction 29849 29884	decreased antithrombin III activity
T150	AdverseReaction 29886 29916	increased levels of fibrinogen
T151	AdverseReaction 29886 29905;29921 29940	increased levels of fibrinogen and fibrinogen activity
T152	AdverseReaction 29942 29971	increased plasminogen antigen
T153	AdverseReaction 29942 29963;29976 29984	increased plasminogen antigen and activity
T154	AdverseReaction 29990 30024	Increased thyroid-binding globulin
T155	AdverseReaction 29990 29999;30026 30029	Increased thyroid-binding globulin (TBG
T156	AdverseReaction 30042 30085	increased circulating total thyroid hormone
T157	AdverseReaction 30042 30051;30130 30139	increased circulating total thyroid hormone, as measured by protein-bound iodine (PBI), T4 levels
T158	AdverseReaction 30042 30051;30179 30188	increased circulating total thyroid hormone, as measured by protein-bound iodine (PBI), T4 levels (by column or by radioimmunoassay), or T3 levels
T159	AdverseReaction 30210 30225;30229 30238	T3 resin uptake is decreased
T160	AdverseReaction 30255 30267	elevated TBG
T161	Factor 30428 30431	may
T162	AdverseReaction 30435 30443;30467 30498	elevated in serum, for example, corticosteroid binding globulin
T163	AdverseReaction 30435 30443;30500 30503	elevated in serum, for example, corticosteroid binding globulin (CBG
T164	AdverseReaction 30435 30443;30506 30534	elevated in serum, for example, corticosteroid binding globulin (CBG), sex hormone-binding globulin
T165	AdverseReaction 30435 30443;30536 30540	elevated in serum, for example, corticosteroid binding globulin (CBG), sex hormone-binding globulin (SHBG
T166	AdverseReaction 30554 30597	increased total circulating corticosteroids
T167	AdverseReaction 30554 30581;30602 30614	increased total circulating corticosteroids and sex steroids
T168	AdverseReaction 30630 30657;30702 30711	Free hormone concentrations, such as testosterone and estradiol, may be decreased
T169	AdverseReaction 30667 30679;30702 30711	testosterone and estradiol, may be decreased
T170	AdverseReaction 30684 30693;30702 30711	estradiol, may be decreased
T171	Factor 30695 30698	may
T172	AdverseReaction 30719 30734;30742 30751	plasma proteins may be increased
T173	Factor 30735 30738	may
T174	AdverseReaction 30742 30751;30753 30768	increased (angiotensinogen
T175	AdverseReaction 30742 30751;30769 30784	increased (angiotensinogen/renin substrate
T176	AdverseReaction 30742 30751;30786 30805	increased (angiotensinogen/renin substrate, alpha-1-antitrypsin
T177	AdverseReaction 30742 30751;30807 30820	increased (angiotensinogen/renin substrate, alpha-1-antitrypsin, ceruloplasmin
T178	AdverseReaction 30827 30868	Increased plasma high-density lipoprotein
T179	AdverseReaction 30827 30836;30870 30873	Increased plasma high-density lipoprotein (HDL
T180	AdverseReaction 30827 30836;30879 30922	Increased plasma high-density lipoprotein (HDL) and HDL2 cholesterol subfraction concentrations
T181	AdverseReaction 30924 30955;30962 30988	reduced low-density lipoprotein (LDL) cholesterol concentrations
T182	AdverseReaction 30924 30931;30957 30960;30962 30988	reduced low-density lipoprotein (LDL) cholesterol concentrations
T183	AdverseReaction 30990 31019	increased triglyceride levels
T184	AdverseReaction 31025 31051	Impaired glucose tolerance
R1	Negated arg1:T13 arg2:T14
R2	Negated arg1:T30 arg2:T31
R3	Hypothetical arg1:T33 arg2:T32
R4	Hypothetical arg1:T37 arg2:T36
R5	Hypothetical arg1:T41 arg2:T40
R6	Hypothetical arg1:T42 arg2:T43
R7	Negated arg1:T45 arg2:T44
R8	Hypothetical arg1:T46 arg2:T49
R9	Hypothetical arg1:T47 arg2:T49
R10	Hypothetical arg1:T48 arg2:T49
R11	Hypothetical arg1:T50 arg2:T51
R12	Hypothetical arg1:T55 arg2:T54
R13	Hypothetical arg1:T56 arg2:T57
R14	Hypothetical arg1:T59 arg2:T58
R15	Hypothetical arg1:T60 arg2:T58
R16	Hypothetical arg1:T61 arg2:T58
R17	Hypothetical arg1:T63 arg2:T62
R18	Hypothetical arg1:T74 arg2:T73
R19	Hypothetical arg1:T76 arg2:T75
R20	Hypothetical arg1:T77 arg2:T79
R21	Hypothetical arg1:T78 arg2:T79
R22	Hypothetical arg1:T80 arg2:T81
R23	Negated arg1:T83 arg2:T82
R24	Hypothetical arg1:T83 arg2:T84
R25	Hypothetical arg1:T85 arg2:T91
R26	Hypothetical arg1:T86 arg2:T91
R27	Hypothetical arg1:T88 arg2:T91
R28	Effect arg1:T88 arg2:T87
R29	Hypothetical arg1:T89 arg2:T91
R30	Hypothetical arg1:T90 arg2:T91
R31	Negated arg1:T93 arg2:T92
R32	Hypothetical arg1:T94 arg2:T98
R33	Hypothetical arg1:T95 arg2:T98
R34	Hypothetical arg1:T96 arg2:T98
R35	Hypothetical arg1:T97 arg2:T98
R36	Hypothetical arg1:T99 arg2:T98
R37	Hypothetical arg1:T100 arg2:T101
R38	Hypothetical arg1:T102 arg2:T103
R39	Hypothetical arg1:T104 arg2:T105
R40	Hypothetical arg1:T107 arg2:T106
R41	Hypothetical arg1:T109 arg2:T108
R42	Hypothetical arg1:T111 arg2:T110
R43	Hypothetical arg1:T112 arg2:T113
R44	Hypothetical arg1:T114 arg2:T115
R45	Hypothetical arg1:T117 arg2:T116
R46	Effect arg1:T120 arg2:T119
R47	Negated arg1:T121 arg2:T122
R48	Hypothetical arg1:T124 arg2:T123
R49	Hypothetical arg1:T125 arg2:T123
R50	Hypothetical arg1:T130 arg2:T129
R51	Hypothetical arg1:T132 arg2:T131
R52	Hypothetical arg1:T162 arg2:T161
R53	Hypothetical arg1:T163 arg2:T161
R54	Hypothetical arg1:T164 arg2:T161
R55	Hypothetical arg1:T165 arg2:T161
R56	Hypothetical arg1:T166 arg2:T161
R57	Hypothetical arg1:T167 arg2:T161
R58	Hypothetical arg1:T168 arg2:T171
R59	Hypothetical arg1:T169 arg2:T171
R60	Hypothetical arg1:T170 arg2:T171
R61	Hypothetical arg1:T172 arg2:T173
R62	Hypothetical arg1:T174 arg2:T173
R63	Hypothetical arg1:T175 arg2:T173
R64	Hypothetical arg1:T176 arg2:T173
R65	Hypothetical arg1:T177 arg2:T173
N1	Reference T1 meddra:10007649	Cardiovascular disorder
N2	Reference T2 meddra:10028997	Neoplasm malignant
N3	Reference T3 meddra:10017626	Gallbladder disorder
N4	Reference T4 meddra:10020869	Hypertriglyceridaemia
N5	Reference T5 meddra:10028334	Muscle spasms
N6	Reference T6 meddra:10028813	Nausea
N7	Reference T7 meddra:10012735	Diarrhoea
N8	Reference T8 meddra:10013946	Dyspepsia
N9	Reference T9 meddra:10000087	Abdominal pain upper
N10	Reference T10 meddra:10068319	Oropharyngeal pain
N11	Reference T11 meddra:10013573	Dizziness
N12	Reference T12 meddra:10028836	Neck pain
N13	Reference T15 meddra:10060800	Hot flush
N14	Reference T26 meddra:10014522	Embolism venous
N15	Reference T27 meddra:10051055	Deep vein thrombosis
N16	Reference T28 meddra:10037377	Pulmonary embolism
N17	Reference T29 meddra:10038908	Retinal vein thrombosis
N18	Reference T34 meddra:10014733	Endometrial cancer
N19	Reference T37 meddra:10012267	Dementia
N20	Reference T46 meddra:10008190	Cerebrovascular accident
N21	Reference T68 meddra:10062108	Retinal vascular thrombosis
N22	Reference T71 meddra:10006187	Breast cancer
N23	Reference T72 meddra:10033128	Ovarian cancer
N24	Reference T76 meddra:10014522	Embolism venous
N25	Reference T120 meddra:10005750	Blood pressure increased
N26	Reference T124 meddra:10005839	Blood triglycerides increased
N27	Reference T125 meddra:10033645	Pancreatitis
N28	Reference T126 meddra:10051420	Thyroxin binding globulin increased
N29	Reference T127 meddra:10051420	Thyroxin binding globulin increased
N30	Reference T128 meddra:10051420	Thyroxin binding globulin increased
N31	Reference T130 meddra:10016807	Fluid retention
N32	Reference T132 meddra:10002424	Angioedema
N33	Reference T133 meddra:10037070	Prothrombin time shortened
N34	Reference T134 meddra:10000637	Activated partial thromboplastin time shortened
N35	Reference T135 meddra:10035518	Platelet aggregation increased
N36	Reference T136 meddra:10051608	Platelet count increased
N37	Reference T137 meddra:10037051	Prothrombin level increased
N38	Reference T138 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N39	Reference T139 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N40	Reference T140 meddra:10009770	Coagulation factor VIII level increased
N41	Reference T141 meddra:10009748	Coagulation factor IX level increased
N42	Reference T142 meddra:10009776	Coagulation factor X level increased
N43	Reference T143 meddra:10009784	Coagulation factor XII level increased
N44	Reference T144 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N45	Reference T145 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N46	Reference T146 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N47	Reference T147 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N48	Reference T148 meddra:10049547	Antithrombin III decreased
N49	Reference T149 meddra:10049547	Antithrombin III decreased
N50	Reference T150 meddra:10005521	Blood fibrinogen increased
N51	Reference T151 meddra:10005521	Blood fibrinogen increased
N52	Reference T152 meddra:10059618	Plasminogen activator inhibitor increased
N53	Reference T153 meddra:10035495	Plasminogen increased
N54	Reference T154 meddra:10051420	Thyroxin binding globulin increased
N55	Reference T156 meddra:10063161	Thyroid hormones increased
N56	Reference T157 meddra:10043818	Thyroxine increased
N57	Reference T158 meddra:10044596	Tri-iodothyronine increased
N58	Reference T159 meddra:10044601	Tri-iodothyronine uptake decreased
N59	Reference T160 meddra:10051420	Thyroxin binding globulin increased
N60	Reference T162 meddra:10072935	Corticosteroid binding globulin increased
N61	Reference T163 meddra:10072935	Corticosteroid binding globulin increased
N62	Reference T164 meddra:10059659	Sex hormone binding globulin increased
N63	Reference T165 meddra:10059659	Sex hormone binding globulin increased
N64	Reference T166 meddra:10020610	Hypercorticoidism
N65	Reference T167 meddra:10005688	Blood oestrogen increased
N66	Reference T168 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N67	Reference T169 meddra:10005814	Blood testosterone decreased
N68	Reference T170 meddra:10030229	Oestradiol decreased
N69	Reference T172 meddra:10037016	Protein total increased
N70	Reference T174 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N71	Reference T175 meddra:DEFAULT_TERM_ID	DEFAULT_TERM
N72	Reference T176 meddra:10001808	Alpha-1 anti-trypsin increased
N73	Reference T177 meddra:10008219	Ceruloplasmin increased
N74	Reference T178 meddra:10020061	High density lipoprotein increased
N75	Reference T179 meddra:10020061	High density lipoprotein increased
N76	Reference T180 meddra:10020061	High density lipoprotein increased
N77	Reference T181 meddra:10024909	Low density lipoprotein decreased
N78	Reference T182 meddra:10024909	Low density lipoprotein decreased
N79	Reference T183 meddra:10005839	Blood triglycerides increased
N80	Reference T184 meddra:10018429	Glucose tolerance impaired
